Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2020

17.04.2020 | Review

Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis

verfasst von: Cameron B. Haas, Larissa Nekhlyudov, Janie M. Lee, Sara H. Javid, Mary Bush, Dianne Johnson, Timothy Gleason, Cary Kaufman, Jennifer Specht, Sean Stitham, Karen J. Wernli

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Women with personal history of breast cancer (PHBC) are currently recommended to receive annual mammography for surveillance of breast cancer recurrence or new primary. However, given issues in accuracy with mammography, there is a need for evolving evidence-based surveillance recommendations with supplemental imaging. In this systematic review, we compiled and compared existing studies that describe the test performance of surveillance breast MRI among women with PHBC.

Methods

We searched PubMed and EMBASE using MeSH terms for studies (2000–2019) that described the diagnostic characteristics of breast MRI in women with PHBC. Search results were reviewed and included based on PICOTS criteria; quality of included articles was assessed using QUADAS-2. Meta-analysis of single proportions was conducted for diagnostic characteristics of breast MRI, including tests of heterogeneity.

Results

Our review included 11 articles in which unique cohorts were studied, comprised of a total of 8338 women with PHBC and 12,335 breast MRI done for the purpose of surveillance. We predict intervals (PI) for cancer detection rate per 1000 examinations (PI 9–15; I2 = 10%), recall rate (PI 5–31%; I2 = 97%), sensitivity (PI 58–95%; I2 = 47%), specificity (PI 76–97%; I2 = 97%), and PPV3 (PI 16–40%; I2 = 44%).

Conclusions

Studies addressing performance of breast MRI are variable and limited in population-based studies. The summary of evidence to date is insufficient to recommend for or against use of breast MRI for surveillance among women with PHBC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Cancer Society (2016) Cancer treatment & survivorship: facts & figures 2016–2017. American Cancer Society, Atlanta, p 44 American Cancer Society (2016) Cancer treatment & survivorship: facts & figures 2016–2017. American Cancer Society, Atlanta, p 44
2.
Zurück zum Zitat Howlader N et al (2016) SEER cancer statistics review, 1975–2013. National Cancer Institute, Bethesda Howlader N et al (2016) SEER cancer statistics review, 1975–2013. National Cancer Institute, Bethesda
4.
Zurück zum Zitat Lash TL et al (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25(21):3001–3006PubMedCrossRef Lash TL et al (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25(21):3001–3006PubMedCrossRef
5.
Zurück zum Zitat Houssami N et al (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20(9):1505–1510PubMedCrossRef Houssami N et al (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20(9):1505–1510PubMedCrossRef
6.
Zurück zum Zitat Lu WL et al (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114(3):403–412PubMedCrossRef Lu WL et al (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114(3):403–412PubMedCrossRef
7.
Zurück zum Zitat Lu W et al (2009) The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer. Eur J Cancer 45(17):3000–3007PubMedCrossRef Lu W et al (2009) The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer. Eur J Cancer 45(17):3000–3007PubMedCrossRef
8.
Zurück zum Zitat Sardanelli F et al (2016) Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol Sardanelli F et al (2016) Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol
9.
Zurück zum Zitat Houssami N et al (2011) Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 305(8):790–799PubMedPubMedCentralCrossRef Houssami N et al (2011) Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 305(8):790–799PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Wernli KJ et al (2019) Surveillance breast MRI and mammography: comparison in women with a personal history of breast cancer. Radiology 292(2):311–318PubMedCrossRef Wernli KJ et al (2019) Surveillance breast MRI and mammography: comparison in women with a personal history of breast cancer. Radiology 292(2):311–318PubMedCrossRef
11.
Zurück zum Zitat Quinn EM, Coveney AP, Redmond HP (2012) Use of magnetic resonance imaging in detection of breast cancer recurrence: a systematic review. Ann Surg Oncol 19(9):3035–3041PubMedCrossRef Quinn EM, Coveney AP, Redmond HP (2012) Use of magnetic resonance imaging in detection of breast cancer recurrence: a systematic review. Ann Surg Oncol 19(9):3035–3041PubMedCrossRef
12.
Zurück zum Zitat American College of Radiology (2013) American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS® Atlas). American College of Radiology (ACR), Reston American College of Radiology (2013) American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS® Atlas). American College of Radiology (ACR), Reston
14.
Zurück zum Zitat Liu Z et al (2013) A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations. Br J Cancer 108(11):2299–2303PubMedPubMedCentralCrossRef Liu Z et al (2013) A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations. Br J Cancer 108(11):2299–2303PubMedPubMedCentralCrossRef
15.
16.
Zurück zum Zitat Innovation VH. Covidence systematic review software Innovation VH. Covidence systematic review software
17.
Zurück zum Zitat Whiting PF et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536PubMedCrossRef Whiting PF et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536PubMedCrossRef
18.
19.
Zurück zum Zitat Berg WA et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18):2151–2163PubMedPubMedCentralCrossRef Berg WA et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18):2151–2163PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Brennan S et al (2010) Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol 195(2):510–516PubMedCrossRef Brennan S et al (2010) Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol 195(2):510–516PubMedCrossRef
21.
Zurück zum Zitat Schacht DV et al (2014) Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol 202(2):289–292PubMedCrossRef Schacht DV et al (2014) Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol 202(2):289–292PubMedCrossRef
22.
Zurück zum Zitat Cho N et al (2017) Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol 3(11):1495–1502PubMedPubMedCentralCrossRef Cho N et al (2017) Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol 3(11):1495–1502PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Elmore L, Margenthaler JA (2010) Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Res 163(1):58–62PubMedCrossRef Elmore L, Margenthaler JA (2010) Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Res 163(1):58–62PubMedCrossRef
24.
Zurück zum Zitat Giess CS et al (2015) Screening breast MRI in patients previously treated for breast cancer: diagnostic yield for cancer and abnormal interpretation rate. Acad Radiol 22(11):1331–1337PubMedCrossRef Giess CS et al (2015) Screening breast MRI in patients previously treated for breast cancer: diagnostic yield for cancer and abnormal interpretation rate. Acad Radiol 22(11):1331–1337PubMedCrossRef
25.
Zurück zum Zitat Gweon HM et al (2014) Breast MR imaging screening in women with a history of breast conservation therapy. Radiology 272(2):366–373PubMedCrossRef Gweon HM et al (2014) Breast MR imaging screening in women with a history of breast conservation therapy. Radiology 272(2):366–373PubMedCrossRef
26.
Zurück zum Zitat Lehman CD et al (2016) Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst 108(3):349CrossRef Lehman CD et al (2016) Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst 108(3):349CrossRef
27.
Zurück zum Zitat Sippo DA et al (2019) Performance of screening breast MRI across women with different elevated breast cancer risk indications. Radiology 292(1):51–59PubMedCrossRef Sippo DA et al (2019) Performance of screening breast MRI across women with different elevated breast cancer risk indications. Radiology 292(1):51–59PubMedCrossRef
29.
Zurück zum Zitat Berg WA et al (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307(13):1394–1404PubMedPubMedCentralCrossRef Berg WA et al (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307(13):1394–1404PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Leeflang MM (2014) Systematic reviews and meta-analyses of diagnostic test accuracy. Clin Microbiol Infect 20(2):105–113PubMedCrossRef Leeflang MM (2014) Systematic reviews and meta-analyses of diagnostic test accuracy. Clin Microbiol Infect 20(2):105–113PubMedCrossRef
31.
Zurück zum Zitat Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20(19):2865–2884PubMedCrossRef Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20(19):2865–2884PubMedCrossRef
32.
Zurück zum Zitat Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMed Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMed
33.
Zurück zum Zitat Zwinderman AH, Bossuyt PM (2008) We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 27(5):687–697PubMedCrossRef Zwinderman AH, Bossuyt PM (2008) We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 27(5):687–697PubMedCrossRef
34.
Zurück zum Zitat Lee CH et al (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18–27PubMedCrossRef Lee CH et al (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18–27PubMedCrossRef
35.
Zurück zum Zitat Ahern CH et al (2014) Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer 111(8):1542–1551PubMedPubMedCentralCrossRef Ahern CH et al (2014) Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer 111(8):1542–1551PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Kramer S et al (1998) Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Res 18(3C):2159–2161PubMed Kramer S et al (1998) Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Res 18(3C):2159–2161PubMed
37.
Zurück zum Zitat Preda L et al (2006) Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res 8(5):R53PubMedPubMedCentralCrossRef Preda L et al (2006) Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res 8(5):R53PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Coulthard A, Beveridge CJ, Potterton AJ (1999) MRI in routine breast cancer follow-up: correlation with clinical outcome. Clin Radiol 54(7):459–461PubMedCrossRef Coulthard A, Beveridge CJ, Potterton AJ (1999) MRI in routine breast cancer follow-up: correlation with clinical outcome. Clin Radiol 54(7):459–461PubMedCrossRef
39.
Zurück zum Zitat Arazi-Kleinman T et al (2013) JOURNAL CLUB: is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results. AJR Am J Roentgenol 201(4):919–927PubMedCrossRef Arazi-Kleinman T et al (2013) JOURNAL CLUB: is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results. AJR Am J Roentgenol 201(4):919–927PubMedCrossRef
40.
Zurück zum Zitat Rieber A et al (1997) Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr 21(5):780–784PubMedCrossRef Rieber A et al (1997) Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr 21(5):780–784PubMedCrossRef
41.
Zurück zum Zitat Viehweg P et al (1998) Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. MAGMA 7(3):141–152PubMedCrossRef Viehweg P et al (1998) Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. MAGMA 7(3):141–152PubMedCrossRef
42.
Zurück zum Zitat Cuzick J et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135–1141PubMedCrossRef Cuzick J et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135–1141PubMedCrossRef
43.
Zurück zum Zitat Dubsky PC et al (2012) Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 30(7):722–728PubMedCrossRef Dubsky PC et al (2012) Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 30(7):722–728PubMedCrossRef
44.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative G et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716CrossRef Early Breast Cancer Trialists’ Collaborative G et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716CrossRef
45.
Zurück zum Zitat Poggi MM et al (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98(4):697–702PubMedCrossRef Poggi MM et al (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98(4):697–702PubMedCrossRef
46.
Zurück zum Zitat Punglia RS, Hassett MJ (2010) Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol 28(27):4108–4110PubMedPubMedCentralCrossRef Punglia RS, Hassett MJ (2010) Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol 28(27):4108–4110PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Veronesi U et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232PubMedCrossRef Veronesi U et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232PubMedCrossRef
48.
Zurück zum Zitat Bassett LW et al (2008) National trends and practices in breast MRI. AJR Am J Roentgenol 191(2):332–339PubMedCrossRef Bassett LW et al (2008) National trends and practices in breast MRI. AJR Am J Roentgenol 191(2):332–339PubMedCrossRef
49.
Zurück zum Zitat Stout NK, Nekhlyudov L (2011) Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. J Womens Health (Larchmt) 20(4):631–634CrossRef Stout NK, Nekhlyudov L (2011) Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. J Womens Health (Larchmt) 20(4):631–634CrossRef
51.
Zurück zum Zitat Khatcheressian JL et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097PubMedCrossRef Khatcheressian JL et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097PubMedCrossRef
52.
Zurück zum Zitat Saslow D et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef Saslow D et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef
53.
Zurück zum Zitat Mainiero MB et al (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 10(1):11–14PubMedCrossRef Mainiero MB et al (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 10(1):11–14PubMedCrossRef
54.
Zurück zum Zitat Khatcheressian JL et al (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(7):961–965PubMedCrossRef Khatcheressian JL et al (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(7):961–965PubMedCrossRef
55.
Zurück zum Zitat Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378(9805):1804–1811PubMedCrossRef Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378(9805):1804–1811PubMedCrossRef
56.
Zurück zum Zitat Sickles EA (2010) The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 48(5):859–878PubMedCrossRef Sickles EA (2010) The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 48(5):859–878PubMedCrossRef
57.
Zurück zum Zitat Monticciolo DL et al (2018) Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 15(3):408–414PubMedCrossRef Monticciolo DL et al (2018) Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 15(3):408–414PubMedCrossRef
58.
Zurück zum Zitat Buist DSM et al (2018) Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med 178(4):458–468PubMedPubMedCentralCrossRef Buist DSM et al (2018) Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med 178(4):458–468PubMedPubMedCentralCrossRef
Metadaten
Titel
Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis
verfasst von
Cameron B. Haas
Larissa Nekhlyudov
Janie M. Lee
Sara H. Javid
Mary Bush
Dianne Johnson
Timothy Gleason
Cary Kaufman
Jennifer Specht
Sean Stitham
Karen J. Wernli
Publikationsdatum
17.04.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05637-y

Weitere Artikel der Ausgabe 2/2020

Breast Cancer Research and Treatment 2/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.